APA

Chen L., Yuan Y., Kar S., Kanchi M. M., Arora S., Kim J. E., Koh P. F., Yousef E., Samy R. P., Shanmugam M. K., Tan T. Z., Shin S. W., Arfuso F., Shen H. M., Yang H., Goh B. C., Park J. I., Gaboury L., Lobie P. E., Sethi G., Lim L. H. K. & Kumar A. P. (20180723). PPARγ Ligand-induced Annexin A1 Expression Determines Chemotherapy Response via Deubiquitination of Death Domain Kinase RIP in Triple-negative Breast Cancers. : Molecular cancer therapeutics.

Chicago

Chen Luxi, Yuan Yi, Kar Shreya, Kanchi Madhu M, Arora Suruchi, Kim Ji E, Koh Pei F, Yousef Einas, Samy Ramar P, Shanmugam Muthu K, Tan Tuan Z, Shin Sung W, Arfuso Frank, Shen Han M, Yang Henry, Goh Boon C, Park Joo I, Gaboury Louis, Lobie Peter E, Sethi Gautam, Lim Lina H K and Kumar Alan P. 20180723. PPARγ Ligand-induced Annexin A1 Expression Determines Chemotherapy Response via Deubiquitination of Death Domain Kinase RIP in Triple-negative Breast Cancers. : Molecular cancer therapeutics.

Harvard

Chen L., Yuan Y., Kar S., Kanchi M. M., Arora S., Kim J. E., Koh P. F., Yousef E., Samy R. P., Shanmugam M. K., Tan T. Z., Shin S. W., Arfuso F., Shen H. M., Yang H., Goh B. C., Park J. I., Gaboury L., Lobie P. E., Sethi G., Lim L. H. K. and Kumar A. P. (20180723). PPARγ Ligand-induced Annexin A1 Expression Determines Chemotherapy Response via Deubiquitination of Death Domain Kinase RIP in Triple-negative Breast Cancers. : Molecular cancer therapeutics.

MLA

Chen Luxi, Yuan Yi, Kar Shreya, Kanchi Madhu M, Arora Suruchi, Kim Ji E, Koh Pei F, Yousef Einas, Samy Ramar P, Shanmugam Muthu K, Tan Tuan Z, Shin Sung W, Arfuso Frank, Shen Han M, Yang Henry, Goh Boon C, Park Joo I, Gaboury Louis, Lobie Peter E, Sethi Gautam, Lim Lina H K and Kumar Alan P. PPARγ Ligand-induced Annexin A1 Expression Determines Chemotherapy Response via Deubiquitination of Death Domain Kinase RIP in Triple-negative Breast Cancers. : Molecular cancer therapeutics. 20180723.